ClinicalTrials.Veeva

Menu

Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AF

M

Medical University of Graz

Status

Completed

Conditions

Atrial Fibrillation
Health Literacy

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT03061123
28-004 ex 15/16

Details and patient eligibility

About

The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC.

The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.

Enrollment

91 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed and ECG-documented non-valvular atrial fibrillation
  • New indication for oral anticoagulation (OAC)
  • Ability of informed consent

Exclusion criteria

  • Existing OAC therapy
  • Valvular heart disease
  • History of valve surgery

Trial contacts and locations

8

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems